Stock Repurchase Plan Authorized by Leidos (NYSE:LDOS) Board of Directors

Leidos (NYSE:LDOS) declared that its board has approved a stock buyback program on Friday, July 31st, RTT News reports. The company plans to repurchase 20,000,000 shares. This repurchase authorization allows the aerospace company to purchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on LDOS. Royal Bank Of Canada reduced their price objective on shares of Leidos from $215.00 to $180.00 and set an “outperform” rating for the company in a research note on Wednesday, May 6th. Wells Fargo & Company set a $125.00 target price on Leidos in a research report on Wednesday, June 17th. Bank of America reaffirmed a “neutral” rating and issued a $125.00 price target (down from $200.00) on shares of Leidos in a report on Wednesday, June 17th. TD Cowen reduced their price target on Leidos from $160.00 to $115.00 and set a “hold” rating for the company in a research report on Tuesday, July 7th. Finally, Jefferies Financial Group decreased their price objective on Leidos from $140.00 to $110.00 and set a “hold” rating on the stock in a research note on Wednesday, July 1st. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, Leidos has a consensus rating of “Hold” and a consensus price target of $163.80.

Leidos Price Performance

NYSE:LDOS traded up $3.25 during mid-day trading on Friday, hitting $115.67. 1,180,183 shares of the stock traded hands, compared to its average volume of 1,314,389. The business’s 50-day moving average price is $113.37 and its 200 day moving average price is $146.78. The company has a quick ratio of 1.29, a current ratio of 1.40 and a debt-to-equity ratio of 1.19. The company has a market cap of $14.55 billion, a PE ratio of 10.59, a price-to-earnings-growth ratio of 1.65 and a beta of 0.54. Leidos has a 12-month low of $98.86 and a 12-month high of $205.77.

Leidos (NYSE:LDOS) last posted its earnings results on Tuesday, May 5th. The aerospace company reported $3.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.25. Leidos had a net margin of 8.15% and a return on equity of 31.92%. The business had revenue of $4.40 billion for the quarter, compared to analysts’ expectations of $4.28 billion. During the same period in the prior year, the company posted $2.97 EPS. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. On average, analysts expect that Leidos will post 12.3 EPS for the current fiscal year.

Insider Activity

In related news, Director Gary Stephen May sold 1,484 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $132.75, for a total value of $197,001.00. Following the sale, the director owned 10,137 shares in the company, valued at approximately $1,345,686.75. This trade represents a 12.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.77% of the company’s stock.

Leidos Company Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.